Novonex   Report issue

For profit Phase 1
Founded: Mississauga ON Canada (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2015
NCT02606773
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Novonex Pharma Kft

Active Ingredients

Drugs in Phase 1 Trials (1)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ascorbic Acid Deficiency (Phase 1)

Scurvy (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1